Ignite Creation Date:
2025-12-25 @ 4:50 AM
Ignite Modification Date:
2025-12-26 @ 3:51 AM
Study NCT ID:
NCT06059118
Status:
RECRUITING
Last Update Posted:
2025-02-25
First Post:
2023-09-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-04
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-15
First Submit QC Date:
None
Study First Post Date:
2023-09-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-21
Last Update Post Date:
2025-02-25
Last Update Post Date Type:
ACTUAL